Biotech news
Americas
The implementation of precision medicine represents a huge, possibly unprecedented, challenge to conventional clinical practice across the breadth of healthcare disciplines, says Daniel Lim of Kirkland & Ellis. 23 October 2018
Americas
Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants. 23 October 2018
Biotech
An EU court ruling on gene-editing regulation has sparked widespread concerns in the scientific and legal communities, as LSIPR finds out. 22 October 2018
Americas
Novartis is planning to acquire Endocyte, an Indiana-based biotech, to accelerate its development of radiopharmaceuticals. 22 October 2018
Americas
AbbVie has announced that it has entered into a licensing deal with Germany-based pharmaceutical company Fresenius Kabi. 22 October 2018
Americas
The US Food and Drug Administration has allowed the first US-based human trial of CRISPR, the gene-editing technology, to proceed. 17 October 2018
Biotech
ERS Genomics, the company providing access to CRISPR/Cas9 IP owned by Emmanuelle Charpentier, has signed a licensing deal with synthetic biology startup Syngulon. 16 October 2018
Americas
Nestlé’s Skin Health unit has been accused of infringing patents and misappropriating trade secrets relating to neurotoxin and derma filler injections. 15 October 2018
Americas
Samsung and HP are just two technology companies that have diversified and invested in the life sciences industry. What impact will this type of activity have on the sector and will it be beneficial in the long run? LSIPR finds out. 15 October 2018
Biotech
The patenting of personalised healthcare inventions has proved problematic in a
number of jurisdictions, but various aspects of these inventions are patentable in Europe, as Laurence Gainey of HGF explains. 12 October 2018